Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Falkenberg

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Social Cognitive and Affective Neuroscience|April 12, 2013
Neural correlates of effective and ineffective mood inductionNils Kohn, Irina Falkenberg, Thilo Kellermann, et al.
Frontiers in Psychiatry|April 26, 2021
The Relationship Between Different Aspects of Theory of Mind and Symptom Clusters in Psychotic Disorders: Deconstructing Theory of Mind Into Cognitive, Affective, and Hyper Theory of MindLaura M-L Dorn, Nele Struck, Florian Bitsch, et al.
Trials|August 11, 2023
The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo designIrina Falkenberg, Florian Bitsch, Wei Liu, et al.
Neuroimage. Clinical|October 18, 2016
Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high riskHuai-Hsuan Tseng, Jonathan P Roiser, Gemma Modinos, et al.
Frontiers in Psychiatry|March 25, 2024
Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysisAlexandros Matsingos, Marcel Wilhelm, Laila Noor, et al.
BMC Psychiatry|October 13, 2023
Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]Amke Müller, Stefan Konigorski, Carina Meißner, et al.
Frontiers in Psychiatry|November 27, 2020
Cortical Complexity in People at Ultra-High-Risk for Psychosis Moderated by Childhood TraumaJiaojiao Hou, Simon Schmitt, Tina Meller, et al.
Schizophrenia Research|October 4, 2016
Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosisIrina Falkenberg, Isabel Valli, Marie Raffin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
Cannabinoid modulation of functional connectivity within regions processing attentional salienceSagnik Bhattacharyya, Irina Falkenberg, Rocio Martin-Santos, et al.
Psychiatry Research|June 15, 2015
Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?Irina Falkenberg, Lucia Valmaggia, Majella Byrnes, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Social Cognitive and Affective Neuroscience|April 12, 2013
Neural correlates of effective and ineffective mood inductionNils Kohn, Irina Falkenberg, Thilo Kellermann, et al.
Frontiers in Psychiatry|April 26, 2021
The Relationship Between Different Aspects of Theory of Mind and Symptom Clusters in Psychotic Disorders: Deconstructing Theory of Mind Into Cognitive, Affective, and Hyper Theory of MindLaura M-L Dorn, Nele Struck, Florian Bitsch, et al.
Trials|August 11, 2023
The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo designIrina Falkenberg, Florian Bitsch, Wei Liu, et al.
Neuroimage. Clinical|October 18, 2016
Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high riskHuai-Hsuan Tseng, Jonathan P Roiser, Gemma Modinos, et al.
Frontiers in Psychiatry|March 25, 2024
Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysisAlexandros Matsingos, Marcel Wilhelm, Laila Noor, et al.
BMC Psychiatry|October 13, 2023
Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]Amke Müller, Stefan Konigorski, Carina Meißner, et al.
Frontiers in Psychiatry|November 27, 2020
Cortical Complexity in People at Ultra-High-Risk for Psychosis Moderated by Childhood TraumaJiaojiao Hou, Simon Schmitt, Tina Meller, et al.
Schizophrenia Research|October 4, 2016
Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosisIrina Falkenberg, Isabel Valli, Marie Raffin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
Cannabinoid modulation of functional connectivity within regions processing attentional salienceSagnik Bhattacharyya, Irina Falkenberg, Rocio Martin-Santos, et al.
Psychiatry Research|June 15, 2015
Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?Irina Falkenberg, Lucia Valmaggia, Majella Byrnes, et al.
Pageof 6